Piramal Pharma’s share price has dropped significantly, trading 4.35% lower at ₹257.95 on the NSE as of 11:02 AM, after plunging as much as 5% earlier to ₹256.7. In contrast, the BSE Healthcare Index is up by 1.0% at 43,880.3, with several other healthcare stocks in the green today.
Performance Highlights
- Piramal Pharma: Despite the recent drop, the stock has shown impressive long-term growth, surging 124.9% over the last year, from ₹114.1 to the current level.
- BSE Healthcare Index: The index has gained 53.2% in the last 12 months, driven by strong performances from healthcare sector stocks.
- Top Gainers in Healthcare: Fortis Healthcare (up 4.4%) and IPCA Labs (up 3.9%) are leading the BSE Healthcare Index gains today.
- Top Losers in Healthcare: Alongside Piramal Pharma, Glenmark Pharma (down 1.4%) and Gland Pharma (down 0.6%) are among the decliners.
Piramal Pharma Share Price history
Day | Open | Close | Change % |
---|---|---|---|
Mon, Nov 11 2024
|
₹281.45
|
₹269.70
|
-4.21%
|
Fri, Nov 8 2024
|
₹292.25
|
₹281.55
|
-3.66%
|
Thu, Nov 7 2024
|
₹294.45
|
₹292.25
|
-0.44%
|
Wed, Nov 6 2024
|
₹275.00
|
₹293.55
|
|
Tue, Nov 5 2024
|
₹275.30
|
₹273.50
|
-0.83%
|
Mon, Nov 4 2024
|
₹284.00
|
₹275.80
|
-2.18%
|
Fri, Nov 1 2024
|
₹272.85
|
₹281.95
|
|
Thu, Oct 31 2024
|
₹250.05
|
₹268.47
|
|
Sectoral Performance Comparison
While Piramal Pharma has delivered a solid annual performance, today’s sharp decline highlights sectoral volatility, particularly as stocks within the BSE Healthcare Index like Jubilant Pharmova (up 208.4%) and Suven Pharmaceuticals (up 121.8%) have recorded robust gains over the last year.
Investors are closely monitoring the healthcare sector for future movements, especially as the market remains dynamic amid ongoing market and economic factors impacting healthcare and pharmaceutical stocks.